Boston Scientific And Angiotech Win Stent Suit

Law360, New York (May 4, 2006, 12:00 AM EDT) -- Medical device makers Boston Scientific Corp. and Angiotech Pharmaceuticals Inc. have emerged victorious in a patent dispute after a Dutch court ruled Sahajanand Medical Technologies Pvt. Ltd.’s drug-eluting stent violated two claims of an Angiotech patent.

The Dutch court confirmed that the Canadian drug company’s patent was valid and Sahajanand’s Infinnium paclitaxel-eluting stent infringed on it. India-based Sahajanand has been ordered to pay for damages as a result of the infringement.

The court also permitted an injunction against Sahajanand, barring the company from selling or delivering...
To view the full article, register now.